Profil
David Preiner is the founder of Biotii Technologies Corp.
(founded in 2018) and Exponential Genomics, Inc. (founded in 2019), where he holds the title of Chief Executive Officer.
He also served as the President & Chief Executive Officer at Medivolve, Inc. from 2021 to 2024.
Prior to that, he worked as the Head-Neuro Diagnostics Technician at The Children's Hospital Corp.
from 2015 to 2019.
Postes actifs de David Preiner
| Sociétés | Poste | Début |
|---|---|---|
Exponential Genomics, Inc.
Exponential Genomics, Inc. BiotechnologyHealth Technology Operates as a bio engineering company | Directeur Général | 01/04/2019 |
Anciens postes connus de David Preiner
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIVOLVE INC. | Directeur Général | 26/08/2024 |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Corporate Officer/Principal | 01/01/2019 |
Biotii Technologies Corp.
Biotii Technologies Corp. Pharmaceuticals: MajorHealth Technology Manufactures synthetic cannabis products | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Medivolve, Inc.
Medivolve, Inc. Information Technology ServicesTechnology Services Provides healthcare technology services and develops a tele-health platform | Technology Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Health Services |
Biotii Technologies Corp.
Biotii Technologies Corp. Pharmaceuticals: MajorHealth Technology Manufactures synthetic cannabis products | Health Technology |
Exponential Genomics, Inc.
Exponential Genomics, Inc. BiotechnologyHealth Technology Operates as a bio engineering company | Health Technology |
















